This content is restricted.
Brief
On 21/07/2025, the Medicines and Healthcare products Regulatory Agency (MHRA) issued an update regarding MHRA's 2024–25 Annual Report and Accounts and Impact Report show progress on safety, innovation, and regulatory excellence. The report highlights significant improvements in core operations, including clearing statutory backlogs, approving new medicines, and launching clinical trial regulatory reforms, demonstrating the agency's commitment to patient safety and access to innovative treatments.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested